These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8467640)

  • 1. Bioassay from two parabolas.
    Moussa MA
    Comput Biol Med; 1993 Jan; 23(1):69-76. PubMed ID: 8467640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonparametric estimation of potency ratio for dilution assays.
    Moussa MA
    Comput Biol Med; 1993 Jan; 23(1):77-82. PubMed ID: 8467641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Different Estimation Methods for Accuracy and Precision in Biological Assay Validation.
    Yu B; Yang H
    PDA J Pharm Sci Technol; 2017; 71(4):297-305. PubMed ID: 28416644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated-measures bioassay with correlated errors and heterogeneous variances: a Monte Carlo study.
    Elashoff JD
    Biometrics; 1981 Sep; 37(3):475-82. PubMed ID: 7317557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of bioassays for quality control.
    Lansky D
    Dev Biol Stand; 1999; 97():157-68. PubMed ID: 10463541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A personal computer-based system for parallel line analysis of bioassay data.
    Iznaga N; Núñez G; Solozabal J; Morales A; Artaza E; Rubio R; Cardenas E
    Comput Methods Programs Biomed; 1995 Jul; 47(2):167-75. PubMed ID: 7587163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the four-parameter logistic model to bioassay: comparison with slope ratio and parallel line models.
    Vølund A
    Biometrics; 1978 Sep; 34(3):357-65. PubMed ID: 719119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Lack-of-Fit Assessment as a System Suitability Test for Potency Assays.
    Li R; Cai W; Zocher M
    PDA J Pharm Sci Technol; 2017; 71(5):368-378. PubMed ID: 28624777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calibration of the Ph. Eur. Biological Reference Preparation (BRP) for tetanus vaccine (adsorbed) batch 3.
    Tierney R; Hockley J; Rigsby P; Terao E; Daas A; Buchheit KH; Sesardic D
    Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):1-26. PubMed ID: 21619853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A curve similarity approach to parallelism testing in bioassay.
    Faya P; Rauk AP; Griffiths KL; Parekh B
    J Biopharm Stat; 2020 Jul; 30(4):721-733. PubMed ID: 32163316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologically active luteinizing hormone (LH) in plasma. 1. Validation of the in vitro bioassay when applied to plasma of women.
    Robertson DM; Diczfalusy E
    Acta Endocrinol (Copenh); 1976 Nov; 83(3):454-65. PubMed ID: 989991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring precision in bioassays: Rethinking assay validation.
    Fay MP; Sachs MC; Miura K
    Stat Med; 2018 Feb; 37(4):519-529. PubMed ID: 29052234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A method for bioassay of potency and effectiveness of inhaled bronchodilators in normal subjects.
    Foster RW; Atanga GK; Carpenter JR; Evans DE; Rakshi K; Small RC
    Br J Clin Pharmacol; 1991 Apr; 31(4):445-55. PubMed ID: 2049254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons of outlier tests for potency bioassays.
    Sondag P; Zeng L; Yu B; Yang H; Novick S
    Pharm Stat; 2020 May; 19(3):230-242. PubMed ID: 31762118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of in-vitro bioassay methods: Application in herbal drug research.
    Indrayanto G; Putra GS; Suhud F
    Profiles Drug Subst Excip Relat Methodol; 2021; 46():273-307. PubMed ID: 33461699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A computer program for parallel line bioassays.
    Finney DJ
    J Pharmacol Exp Ther; 1976 Aug; 198(2):497-506. PubMed ID: 948040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the normocythemic mice bioassay for the potency evaluation of recombinant human erythropoietin in pharmaceutical formulations.
    Barth T; Oliveira PR; D'Avila FB; Dalmora SL
    J AOAC Int; 2008; 91(2):285-91. PubMed ID: 18476339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recombinant human erythropoietin: method of in vivo evaluation using normocythemic mice].
    Albertengo ME; Valcarce GA; Oliva LM; Baiges DL; Alonso BS; Chiale CA
    Sangre (Barc); 1999 Oct; 44(5):357-63. PubMed ID: 10618913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and in-house validation of a microbiological assay for determination of cefepime in injectable preparations.
    Souza MJ; Kulmann RR; Silva LM; Nogueira DR; Zimmermann ES; Schmidt CA
    J AOAC Int; 2006; 89(5):1367-72. PubMed ID: 17042189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technical comments on the bioassay of erythropoietin.
    Dunn CD; Napier JA
    Exp Hematol; 1978 Aug; 6(7):577-84. PubMed ID: 689123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.